ZAGMATERM Trademark

Trademark Overview

On Tuesday, March 18, 2014, a trademark application was filed for ZAGMATERM with the United States Patent and Trademark Office. The USPTO has given the ZAGMATERM trademark a serial number of 79146866. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, March 19, 2024. This trademark is owned by Novartis AG. The ZAGMATERM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of symptoms in connection with oncology
zagmaterm

General Information

Serial Number79146866
Word MarkZAGMATERM
Filing DateTuesday, March 18, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, March 19, 2024
Registration Number4603880
Registration DateTuesday, September 16, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 1, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment of symptoms in connection with oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, April 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSandoz AG
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Monday, May 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 1, 2014PUBLISHED FOR OPPOSITION
Thursday, May 15, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 23, 2014APPLICATION FILING RECEIPT MAILED
Tuesday, May 27, 2014ASSIGNED TO EXAMINER
Wednesday, May 28, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 11, 2014NOTICE OF PUBLICATION
Tuesday, September 16, 2014REGISTERED-PRINCIPAL REGISTER
Thursday, October 16, 2014GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Thursday, January 15, 2015FINAL DISPOSITION PROCESSED
Thursday, January 15, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, January 30, 2015NOTIFICATION PROCESSED BY IB
Friday, April 2, 2021CANCELLED SECTION 71
Monday, June 27, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, December 2, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, April 16, 2022INVALIDATION PROCESSED
Saturday, April 16, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, January 19, 2024CHANGE OF OWNER RECEIVED FROM IB
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Tuesday, October 8, 2024DEATH OF INTERNATIONAL REGISTRATION
Tuesday, October 8, 2024DEATH OF INTERNATIONAL REGISTRATION

Related Keywords

zagmaterm connection oncology symptoms treatment preparations human pharmaceutical